Anyway if that combination can take OS from a mediocre 13 months to PFS of 13 months then OS could be in the 20s or close to it.
I'd imagine that t enzalutemide with TLX591 with an OS already in the 40 months range would end up with OS in the 50 months.
That's really meaningful survival; over 4 years, especially considering most patients would be in their 60s at least.
Hopefully it turns out to be the case.
Understanding Telix, page-1085
-
- There are more pages in this discussion • 109 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.85 |
Change
-1.460(7.19%) |
Mkt cap ! $6.307B | |||
| Open | High | Low | Value | Volume |
| $18.92 | $19.57 | $18.68 | $107.9M | 5.682M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 14410 | $18.85 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.99 | 2500 | 1 |
View Market Depth
| Last trade - 16.10pm 24/07/2024 (20 minute delay) ? |
| TLX (ASX) Chart |